6U6O image
Deposition Date 2019-08-30
Release Date 2021-03-24
Last Version Date 2024-10-09
Entry Detail
PDB ID:
6U6O
Keywords:
Title:
Crystal structure of a vaccine-elicited anti-HIV-1 rhesus macaque antibody DH846
Biological Source:
Source Organism:
Macaca mulatta (Taxon ID: 9544)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.81 Å
R-Value Free:
0.27
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:DH846 Fab heavy chain
Chain IDs:A (auth: H)
Chain Length:228
Number of Molecules:1
Biological Source:Macaca mulatta
Polymer Type:polypeptide(L)
Molecule:DH846 Fab light chain
Chain IDs:B (auth: L)
Chain Length:213
Number of Molecules:1
Biological Source:Macaca mulatta
Primary Citation
Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates.
Plos Pathog. 17 e1009624 e1009624 (2021)
PMID: 34086838 DOI: 10.1371/journal.ppat.1009624

Abstact

A primary goal of HIV-1 vaccine development is the consistent elicitation of protective, neutralizing antibodies. While highly similar neutralizing antibodies (nAbs) have been isolated from multiple HIV-infected individuals, it is unclear whether vaccination can consistently elicit highly similar nAbs in genetically diverse primates. Here, we show in three outbred rhesus macaques that immunization with Env elicits a genotypically and phenotypically conserved nAb response. From these vaccinated macaques, we isolated four antibody lineages that had commonalities in immunoglobulin variable, diversity, and joining gene segment usage. Atomic-level structures of the antigen binding fragments of the two most similar antibodies showed nearly identical paratopes. The Env binding modes of each of the four vaccine-induced nAbs were distinct from previously known monoclonal HIV-1 neutralizing antibodies, but were nearly identical to each other. The similarities of these antibodies show that the immune system in outbred primates can respond to HIV-1 Env vaccination with a similar structural and genotypic solution for recognizing a particular neutralizing epitope. These results support rational vaccine design for HIV-1 that aims to reproducibly elicit, in genetically diverse primates, nAbs with specific paratope structures capable of binding conserved epitopes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback